Geninn Life Sciences Private Limited
About Geninn Life Sciences Private Limited
Data last updated:
Geninn Life Sciences Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 October 2019.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2019PTC136520.
The company had an authorised share capital of ₹4.2 Cr and a paid-up capital of ₹10 Lakh. It was led by directors Srinivas Vasireddy and Venugopal Ghanta.
Its last annual general meeting (AGM) was held on 18 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office was at Plot No. 3 4 & 5 Anrich Industrial Estate Bollaram, Hyderabad, Telangana, India – 502325.
As per the financials filed for FY 2025, the company reported a revenue of ₹35.75 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹22.37 Lakh (net margin 62.6%) and EBITDA of ₹29.9 Lakh (EBITDA margin 83.6%). Revenue has grown at a compounded annual rate (CAGR) of 87% over three years.
As per MCA filings, the company had open charges of ₹50.64 Cr on record.
Company details
Contact details
Geninn Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. 3 4 & 5 Anrich Industrial Estate Bollaram, Hyderabad, Telangana, India – 502325
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Geninn Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Geninn Life Sciences Private Limited
FY 2025 filings availableGeninn Life Sciences Private Limited reported revenue of ₹35.75 Lakh (up 174% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 87% over three years, including 174% growth in the latest year. EBITDA rose 391% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.9 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22.37 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 83.6% | ||||
| Net Profit Margin | 62.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Geninn Life Sciences Private Limited, buy the company report.
Board of directors of Geninn Life Sciences Private Limited
Geninn Life Sciences has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivas Vasireddy Also directs: Viyash Scientific Limited, Alivira Animal Health Limited | Director | 22 Oct 2022 | 4 Years 0 Months | As last reported |
| Venugopal Ghanta | Director | 05 Jun 2021 | 5 Years 5 Months | As last reported |
Auditor
Geninn Life Sciences Private Limited is audited by DELOITTE HASKINS & SELLS for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DELOITTE HASKINS & SELLS | FY 2023 | 008072S |
Shareholding
The shareholding of Geninn Life Sciences Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Geninn Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Sep 2025 | 101177005 | Hdfc Bank Limited | ₹16.53 Lakh | Open | |
| 28 Dec 2019 | 100314217 | Hdfc Bank Limited | ₹26.65 Cr | Open | |
| 06 Dec 2019 | 100316824 | Others | ₹23.83 Cr | Open |
To see the full charge records of Geninn Life Sciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Geninn Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Geninn Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Geninn Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Geninn Life Sciences Private Limited has 6 board changes on record since 2020: 2 appointments and 4 cessations. The latest: Srinivas Vasireddy ceased to be Additional Director on 27 Dec 2022.
2 earlier events are in the company report.
Frequently asked questions
Geninn Life Sciences has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Geninn Life Sciences was a private limited company based in Hyderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 31 October 2019 and is registered under CIN U24299TG2019PTC136520. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Geninn Life Sciences was incorporated on 31 October 2019. It is registered with the Registrar of Companies, Hyderabad.
Geninn Life Sciences had 2 directors:
- Srinivas Vasireddy - Director
- Venugopal Ghanta - Director
The CIN (Corporate Identification Number) of Geninn Life Sciences is U24299TG2019PTC136520. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Geninn Life Sciences is at Plot No. 3 4 & 5 Anrich Industrial Estate Bollaram, Hyderabad, Telangana, India – 502325.
The latest financial statements of Geninn Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 18 July 2025. Year-wise statements from FY 2020 are in the company report.
Geninn Life Sciences operated in the pharma industry, in the drug formulation and development segment.
Srinivas Vasireddy ceased to be Additional Director on 27 Dec 2022. Srinivas Vasireddy was appointed as Director on 22 Oct 2022. Hari Babu Bodepudi ceased to be Director on 05 Jun 2021. Geninn Life Sciences has 6 board changes on record in total.
Geninn Life Sciences has open charges of ₹50.64 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
